The AHA and other plaintiffs late Friday asked a federal district judge to set a firm June deadline for the Department of Health and Human Services to propose remedies to the nearly 30 percent cuts to Medicare payments affecting certain hospitals that participate in the 340B Drug Pricing Program. The judge last week had set an Aug. 5 deadline for the remedies.
 
In the filing, the plaintiffs said “it is important that the Court require HHS to propose its remedy by the end of June 2019 or shortly thereafter, since unless there is a Court order on the remedy in this case this summer, Defendants may issue a 2020 OPPS [outpatient prospective payment system] rule reducing reimbursements for 340B drugs by nearly 30 percent in violation of law, just as they did in 2018 and 2019.” While the final OPPS rule generally is issued by the Centers for Medicare & Medicaid Services in November, the agency typically issues its proposal in late July. 
 
A federal district court judge last week said HHS would get "first crack at crafting appropriate remedial measures" to the cuts, and also held that, like the 2018 cuts, the 2019 cuts to 340B hospitals were unlawful.
 

Headline
The Centers for Medicare & Medicaid Services has released a fact sheet and FAQs on the 340B Part D claims data repository that will go live Oct. 1. Data…
Headline
The AHA Aug. 26 urged the Centers for Medicare & Medicaid Services not to finalize two proposals in the calendar year 2027 outpatient prospective payment…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…
Headline
The 2027 AHA Rural Healthcare Leadership Conference will be held Jan. 31-Feb. 3 in Orlando, Fla. Join fellow rural hospital CEOs, senior executives, clinical…
Headline
A bipartisan group of senators Aug. 5 introduced the Supporting Underserved and Strengthening Transparency, Accountability and Integrity Now and for the Future…
Headline
The Department of Health and Human Services today issued a notice announcing a revised 340B Rebate Model Pilot Program, allowing qualifying drug manufacturers…